Is a warming planet forcing fungi to evolve into deadly human pathogens?
In short: Candida auris is a multidrug-resistant yeast that thrives in hospital environments and carries a mortality rate of up to 60 percent. First identified in 2009, this emerging pathogen is uniquely adapted to survive on human skin and inanimate surfaces, sparking global concern as it spreads across healthcare facilities worldwide.
First described in 2009 after being isolated from a patient's ear canal in Tokyo, Candida auris has rapidly become a significant global health threat. Unlike most other Candida species, this fungus can grow at high temperatures, leading some researchers to hypothesize that global warming is selecting for thermally tolerant fungal lineages capable of infecting humans. This evolutionary shift may be further complicated by the widespread use of agricultural azole-type antifungals, which could have contributed to the development of multidrug resistance observed in various clades of the pathogen.
The clinical danger of C. auris lies in its ability to colonize skin and persist on medical equipment, facilitating outbreaks in long-term care facilities. Once it enters the bloodstream, it can cause invasive candidiasis, infecting internal organs and the central nervous system. Treatment is notoriously difficult; the fungus is frequently misidentified by standard laboratory tests, and many isolates show resistance to fluconazole, voriconazole, and amphotericin B. While echinocandins are typically effective, some strains have emerged that are resistant to all major classes of antifungal medication.
The fungus employs sophisticated survival strategies, including switching between distinct cell states to adapt to harsh environments and utilizing a specific adhesion protein to form biofilms. Recent research indicates that C. auris can even metabolize ambient carbon dioxide to sustain its energy needs, a process that enhances its fitness on human skin. As of 2022, the World Health Organization has classified it as a critical priority pathogen. Despite ongoing efforts, no human vaccine exists, and containment remains heavily reliant on rigorous infection control, such as specialized surface disinfection and patient screening in healthcare settings.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: Candida auris
- Also: Pathogenicity and virulence of <i>Candida auris</i>.
To cite this card, link to https://intellectplus.co.uk/app/health-candida-auris.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Health, medicine and disease · More in Health · Latest · A–Z · All topics